TY  - CONF

T1  - Clinical fracture incidence in metastatic hormone-sensitive prostate cancer and risk-reduction following addition of zoledronic acid to androgen deprivation therapy with or without docetaxel: Long-term results from the STAMPEDE trial

JO  - EUROPEAN UROLOGY

PY  - 2023/01/01

AU  - Jones C

AU  - Sachdeva A

AU  - Murphy L

AU  - Murray M

AU  - Brown L

AU  - Brown J

AU  - Mc CE

AU  - Attard G

AU  - Parmar M

AU  - James N

AU  - Sydes MR et al

ED  - 

VL  - 83

Y2  - 2024/09/19

ER  -